Unlock the Editor’s Digest totally free Roula Khalaf, Editor of the FT, selects her favorite tales on this weekly e-newsletter. Hovering gross sales of Eli Lilly’s vastly widespread diabetes and weight reduction medicine Mounjaro and Zepbound prompted the US pharmaceutical group to elevate its steerage for the 12 months and pushed its share worth in...
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Eli Lilly lifts guidance after sales of Mounjaro and Zepbound drugs soar
You may also like
Contact Information
- Do not hesitate to contact us if you have questions about the subscription or your ads publish. We are here to help!
- E-mail at [email protected]
- Give us a call at our toll-free number: ((888) 503-2390